ALB |
Albumin |
BCP-ALL |
B-cell precursor acute lymphoblastic leukemia |
BFM |
Berlin-Frankfurt–Münster |
BM |
Bone marrow |
CNSL |
Central nervous system leukemia |
CODPL |
Cyclophosphamide and prednisone/dexamethasone, vincristine,
daunorubicin/idarubicin, and L-asparaginase |
COG |
Children’s Oncology Group |
CR |
Complete remission |
EFS |
Event-free survival |
FISH |
Fluorescence in situ hybridization |
HSCT |
Hematopoietic stem cell transplantation |
HR |
High risk |
IR |
Intermediate risk |
LDH |
Lactate dehydrogenase |
MICM |
Morphology-immunology-cytogenetics-molecular |
MLPA |
Multiplex ligation probe-dependent amplification |
MRD |
Minimal residual disease |
OS |
Overall survival |
RQ-PCR |
Real-time quantitative polymerase chain reaction |
SNP |
Single nucleotide polymorphism |
TKI |
Tyrosine kinase inhibitor |
UA |
Uricacid |
WBC |
White blood cell |